Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.
Niagen Bioscience, Inc. Common Stock (NAGE) has a market cap of $375.58M with year-over-year revenue growth of +19.2%. Net margin stands at 8.6%. The stock trades at a P/E ratio of 43.9.
Compared to other companies in the MEDICINAL CHEMICALS & BOTANICAL PRODUCTS sector, NAGE posted revenue growth of +19.2% and trades at a P/E of 43.9.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.